Mon Laferte

Mon Laferte, born Norma Monserrat Bustamante Laferte on November 2, 1983, in Vina del Mar, Chile, is one of Latin America’s most acclaimed singer-songwriters. She began performing as a teenager, competing on the Chilean television talent show “Rojo Fama Contrafama” in 2003, which gave her early national exposure. After years of building her craft in Chile, she relocated to Mexico City in 2007, where she reinvented herself artistically and adopted the stage name Mon Laferte. Her fusion of Latin pop, rock, bolero, and ranchera styles quickly resonated with audiences across Latin America.

Mon Laferte’s breakthrough came with her 2015 album “Mon Laferte Vol. 1,” which featured the hit single “Tu Falta de Querer.” The song became a massive viral success, accumulating hundreds of millions of streams and establishing her as a leading voice in Latin alternative music. She followed up with critically acclaimed albums including “La Trenza” (2017) and “Norma” (2018), each showcasing her versatility and emotional depth as a songwriter. Her willingness to experiment with genres ranging from cumbia to indie rock has earned her a devoted and diverse fanbase.

Her career achievements include multiple Latin Grammy Awards, with wins for Best Alternative Music Album and Best Singer-Songwriter Album among others. She made international headlines at the 2019 Latin Grammy Awards when she bared her chest on the red carpet with the message “En Chile torturan, violan y matan” in protest of human rights abuses during the Chilean social unrest. Beyond music, Mon Laferte is also an accomplished visual artist, having exhibited her paintings in galleries across Latin America.

By 2026, Mon Laferte’s net worth is estimated at $5 million, built through consistent album releases, sold-out concert tours across the Americas and Europe, merchandise sales, and her growing art career. She continues to be one of the most important and outspoken artists in the Latin music scene, with a catalog that spans over a decade of critically acclaimed work.